The American Academy of Ophthalmology and the American Academy of Optometry have announced a joint initiative to work together to prepare and better support their members in delivering the highest quality eye care.
The Center for Medicare and Medicaid Services (CMS) has published the permanent Health-Care Common Procedure Coding System (HCPCS) code for ThromboGenics’ ocriplasmin (Jetrea), J7316.
According to a new study that examined the real-world usage of ranibizumab (Lucentis, Genentech) and aflibercept (Eylea, Regeneron), patients with wet age-related macular degeneration (AMD) required an equivalent number of injections over 6- and 12-month periods for both treatments.
Shire has announced the results from OPUS-2, a phase III efficacy and safety study of its treatment of dry eye, 5.0% lifitegrast ophthalmic solution.
Chronic pain can occur after refractive surgery, but it also can occur in patients with non-surgical ocular disease. It is important to distinguish both the causes and the manifestations of pain before one can successfully treat it, according to Todd P. Margolis, MD, PhD.